Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection
about
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceHTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune statusIL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyKIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapyNatural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patientsLong-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.Natural killer cell-based therapies.KIR/HLA interactions and pathogen immunityNK cells, innate immunity and hepatitis C infection after liver transplantation.KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolutionKiller-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reactionInherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C VirusDiversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcomeA polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Frequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.NK cells: immune cross-talk and therapeutic implications.Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.Glances in Immunology of HIV and HCV InfectionIL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C.Individualization of chronic hepatitis C treatment according to the host characteristics.Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chrHost genetics in immune-mediated hepatitis C virus clearance.Maternal KIR and fetal HLA-C: a fine balance.Hepatitis C virus-mediated modulation of cellular immunity.Natural killer cells in hepatitis C virus infection.Innate and adaptive genetic pathways in HCV infection.NK cells: tuned by peptide?Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil.Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users.Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.Killer cell immunoglobulin-like receptor (KIR) gene diversity in a population naturally exposed to malaria in Porto Velho, Northern Brazil.IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells.Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C.KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome
P2860
Q26850968-42C64EE6-F99D-4455-A549-8E0460C61806Q26866444-2381C4B8-D625-4DFE-B42F-72323EFC89D4Q28477057-F3F9637A-4700-4B25-AA2A-9F92F6F7AB5BQ28477797-7ACBDD43-09A4-4C3E-B0B4-9AB4A370DA43Q31115968-EBDFB876-EE8C-44D1-A3FA-2DAE2A3675DDQ33588171-0FCF23D3-6A5B-45EA-ABFC-75A922F62BABQ34988727-63B8E73B-41B1-43B0-A084-FAD0EA74F87EQ35001169-07247BD5-63C7-42F8-A620-B069B0171631Q35019869-D3CD14E3-5077-4497-91A8-75768A0158A5Q35070933-9C7EED1E-4C9B-4BF0-93E1-541F0E6C9671Q35121645-298F3BE0-4C82-4A76-9940-7744C0FB47ACQ35148027-9585A813-AEB0-41A1-BDE6-34DF8527DD8CQ35158581-AC0D7F8E-7B03-4A45-A005-F92FDF289B3AQ35187793-B647B371-83D0-463D-9238-260EC8120BE8Q35356926-2DBC8863-71FC-49E5-B603-DE4E66A887D7Q35511598-D2F70B54-1E46-4DF4-9A4B-888A7E154FD4Q35591444-B94292C6-8AEA-4DDA-ABFC-F12CB79CA32CQ35808616-4E8DB73C-DB79-42F6-84F9-03FFE21FA970Q36032051-1793161A-8E22-4D74-947B-E4B0DB1819C5Q37226696-7C47B806-3187-4E17-B7A0-32B71D23F9C9Q37654502-EAB78DEA-6A57-496E-9444-92ED1C3619E9Q37719750-0EE6AE7C-FE96-472F-B837-817E88DDE21AQ37862746-4717065E-F3F2-4E36-A222-CC4772F91813Q37923237-EBA7014F-A131-43E2-A1BF-E4E3D38F72B2Q38036576-2EB231CA-9DC0-442C-BB9A-D9A8FDED258EQ38061192-F37CE9F6-6A61-4572-9F0F-A60702A5FFB7Q38364524-3721B5C1-8AD6-4B30-B3A1-C5641E78DA9EQ38568884-D8124727-AE5E-45F5-B06D-D572FA69ED79Q39555726-A7361547-D2BD-497E-8C35-CC90378F376BQ41682815-23FFE342-2F2E-40E4-9867-E1AE74D03DD7Q41993469-CBF3E6B1-52DB-4526-B581-FE82B8B08E69Q42232714-A6307D05-65E1-4764-918D-69D2E3DF3D84Q43037932-C4372AA9-4CC6-4AA0-AF7F-91BA7B1C5192Q43038593-6764BBE6-CABA-4BFD-9D44-2BAD121E44B1Q44397350-27DB1091-93C2-4E53-93BB-1C3419EB8E16Q47738030-011D8CF6-956E-40C4-92AE-DCC6DA517FABQ48337795-E9E10A04-8075-4B5E-B4AC-F56DBE3590D2Q55311659-06FC68C6-43CB-484A-A0E4-1ACB68112BA6Q58701375-5655A5E7-2EDD-4112-99D1-80B5BC9842BD
P2860
Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@ast
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@en
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@nl
type
label
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@ast
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@en
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@nl
prefLabel
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@ast
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@en
Effect of Killer Immunoglobuli ...... ic Hepatitis C Virus Infection
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Effect of killer immunoglobuli ...... ic hepatitis C virus infection
@en
P2093
A López-Vázquez
C López-Larrea
J Fernández-Suárez
J Martínez-Borra
P2860
P304
P3181
P356
10.1128/JVI.01285-09
P577
2010-01-01T00:00:00Z